BridgeBio Oncology Therapeutics (BBOT), a company advancing small molecule therapeutics targeting RAS and PI3Ka malignancies, ...
BridgeBio Oncology has entered a definitive merger agreement with Helix Acquisition Corp II, which will result in the ...